Goodwin Procter recently advised Paramount Group Inc. in connection with its initial public offering of 131 million shares of common stock. Shares priced at $17.50 per share, making the offering the largest IPO in the REIT industry since it was first established 50 years ago. The company is listed on the New York Stock Exchange and shares began trading on November 19, 2014 under the ticker “PGRE.” More >>
Tags: Goodwin Procter LLP | BostonThe Tokyo office of Simpson Thatcher recently represented Recruit Holdings Co., Ltd. (“Recruit”) in connection with its initial public offering on the Tokyo Stock Exchange and global offering to institutional investors pursuant to Rule 144A and Regulation S under the Securities Act. Recruit sold 21,589,600 shares in the international offering, with an additional 6,000,000 shares sold by the selling shareholders in the international offering. More >>
Tags: Tokyo
Simpson Thacher acted as sole international counsel in connection with the update of the US$8 billion global medium term notes program and the offering of US$300 million 2.75% Notes due 2019 by NongHyup Bank. The offering was conducted in reliance upon Rule 144A and Regulation S under the U.S. Securities Act of 1933, as amended. More >>
Tags: Simpson Thacher & Bartlett LLP | Seoul
Paul, Weiss client Canadian Natural Resources Limited, a Canadian energy company, completed a public offering in the United States of $1.2 billion of debt securities in two tranches: $600 million of 1.750% notes due 2018 and $600 million of 3.900% notes due 2025. The joint bookrunning managers were Citigroup Global Markets Inc., Barclays Capital Inc., J.P. Morgan Securities LLC, Mitsubishi UFJ Securities (USA), Inc. and RBS Securities Inc. More >>
Tags: Foley & Lardner LLP | New YorkGoodwin Procter attorneys recently advised Royalty Pharma in a $3.3 billion acquisition of the Cystic Fibrosis Foundation’s royalties on Vertex Pharmaceuticals’ cystic fibrosis treatments, the largest pharmaceutical royalty purchase ever completed. Funds will be used to expand cystic fibrosis research, care and service programs. More >>
Tags: Goodwin Procter LLP | Boston | San Francisco
Cravath represented the underwriters, led by J.P. Morgan Securities, BofA Merrill Lynch and Wells Fargo Securities, in connection with the US$120 million registered secondary offering of class A common stock of Premier, Inc., a leading healthcare improvement company. The shares were listed on the NASDAQ Global Select Market. The transaction closed on November 19, 2014. More >>
Tags: Cravath, Swaine & Moore LLP | New York
Clifford Chance is advising DP World Limited (DP World) on the proposed acquisition of Economic Zones World FZE (EZW) from Port and Free Zone World FZE (PFZW) for total cash consideration of US$2.6 billion, subject to certain adjustments, and its proposed delisting from the London Stock Exchange.
EZW is the holding company for the Jebel Ali Free Zone, a 57 square kilometre modern commercial and industrial logistics park adjacent to DP World’s flagship Jebel Ali port in Dubai. The free zone is considered an integral component of the supply chain for DP World’s customers at the Jebel Ali port. More >>
Tags: Clifford Chance LLP | London
Ashurst has advised export credit agencies Japan Bank for International Cooperation (‘JBIC’), Korea Ex-Im Bank (‘KEXIM’), Nippon Export and Investment Insurance (‘NEXI’) and the commercial banks on the US$2.8 billion financing for the Donggi-Senoro LNG project in Indonesia, which signed on 14 November.
The lenders included JBIC, KEXIM, Mizuho Corporate Bank, Bank of Tokyo Mitsubishi, Sumitomo Mitsui Banking Corporation, Korea Exchange Bank and NongHyup Bank. More >>
Tags: Ashurst | Hong Kong
Weil’s Antitrust team is representing Actavis in its just announced acquisition of Allergan, a transaction valued at $66 billion. More >>
Tags: Weil, Gotshal & Manges, LLP | Washington